Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-28 @ 3:50 PM
Study NCT ID:
NCT04809766
Status:
TERMINATED
Last Update Posted:
2025-04-20
First Post:
2021-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-19
First Submit QC Date:
None
Study First Post Date:
2021-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-16
Last Update Post Date:
2025-04-20
Last Update Post Date Type:
ACTUAL